NHI Valuation
National Health Investors Inc
$
73.860
- Overview
- Forecast
- Valuation
- Earnings
NHI Relative Valuation
NHI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NHI is overvalued; if below, it's undervalued.
Historical Valuation
National Health Investors Inc (NHI) is now in the Fair zone, suggesting that its current forward PE ratio of 23.21 is considered Fairly compared with the five-year average of 20.54. The fair price of National Health Investors Inc (NHI) is between 67.76 to 84.11 according to relative valuation methord.
Relative Value
Fair Zone
67.76-84.11
Current Price：74.45
Fair
23.30
PE
1Y
3Y
5Y
Trailing
Forward
15.13
EV/EBITDA
National Health Investors Inc. (NHI) has a current EV/EBITDA of 15.13. The 5-year average EV/EBITDA is 15.22. The thresholds are as follows: Strongly Undervalued below 12.51, Undervalued between 12.51 and 13.86, Fairly Valued between 16.57 and 13.86, Overvalued between 16.57 and 17.93, and Strongly Overvalued above 17.93. The current Forward EV/EBITDA of 15.13 falls within the Historic Trend Line -Fairly Valued range.
21.14
EV/EBIT
National Health Investors Inc. (NHI) has a current EV/EBIT of 21.14. The 5-year average EV/EBIT is 21.47. The thresholds are as follows: Strongly Undervalued below 15.58, Undervalued between 15.58 and 18.53, Fairly Valued between 24.41 and 18.53, Overvalued between 24.41 and 27.35, and Strongly Overvalued above 27.35. The current Forward EV/EBIT of 21.14 falls within the Historic Trend Line -Fairly Valued range.
9.43
PS
National Health Investors Inc. (NHI) has a current PS of 9.43. The 5-year average PS is 8.80. The thresholds are as follows: Strongly Undervalued below 6.40, Undervalued between 6.40 and 7.60, Fairly Valued between 9.99 and 7.60, Overvalued between 9.99 and 11.19, and Strongly Overvalued above 11.19. The current Forward PS of 9.43 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
National Health Investors Inc. (NHI) has a current P/OCF of 0.00. The 5-year average P/OCF is 4.06. The thresholds are as follows: Strongly Undervalued below -6.28, Undervalued between -6.28 and -1.11, Fairly Valued between 9.24 and -1.11, Overvalued between 9.24 and 14.41, and Strongly Overvalued above 14.41. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
National Health Investors Inc. (NHI) has a current P/FCF of 0.00. The 5-year average P/FCF is 1.87. The thresholds are as follows: Strongly Undervalued below -6.07, Undervalued between -6.07 and -2.10, Fairly Valued between 5.84 and -2.10, Overvalued between 5.84 and 9.81, and Strongly Overvalued above 9.81. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
National Health Investors Inc (NHI) has a current Price-to-Book (P/B) ratio of 2.41. Compared to its 3-year average P/B ratio of 2.14 , the current P/B ratio is approximately 13.05% higher. Relative to its 5-year average P/B ratio of 2.03, the current P/B ratio is about 18.97% higher. National Health Investors Inc (NHI) has a Forward Free Cash Flow (FCF) yield of approximately 5.83%. Compared to its 3-year average FCF yield of 6.98%, the current FCF yield is approximately -16.47% lower. Relative to its 5-year average FCF yield of 7.31% , the current FCF yield is about -20.18% lower.
2.42
P/B
Median3y
2.14
Median5y
2.03
5.83
FCF Yield
Median3y
6.98
Median5y
7.31
Competitors Valuation Multiple
The average P/S ratio for NHI's competitors is 6.39, providing a benchmark for relative valuation. National Health Investors Inc Corp (NHI) exhibits a P/S ratio of 9.43, which is 47.63% above the industry average. Given its robust revenue growth of 6.70%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NHI decreased by 8.57% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 84.97M to 90.66M.
The secondary factor is the Margin Expansion, contributed -1.60%to the performance.
Overall, the performance of NHI in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
PII
Polaris Inc
57.900
USD
-2.71%
PATK
Patrick Industries Inc
113.005
USD
-0.93%
AEO
American Eagle Outfitters Inc
12.875
USD
-4.77%
VCYT
Veracyte Inc
29.780
USD
-2.93%
HUN
Huntsman Corp
9.975
USD
-1.63%
FHI
Federated Hermes Inc
53.860
USD
+0.39%
TRN
Trinity Industries Inc
27.880
USD
-3.46%
OUT
OUTFRONT Media Inc
18.425
USD
-1.89%
SXT
Sensient Technologies Corp
114.020
USD
-5.59%
WDFC
WD-40 Co
222.440
USD
-1.55%
FAQ
Is National Health Investors Inc (NHI) currently overvalued or undervalued?
National Health Investors Inc (NHI) is now in the Fair zone, suggesting that its current forward PE ratio of 23.21 is considered Fairly compared with the five-year average of 20.54. The fair price of National Health Investors Inc (NHI) is between 67.76 to 84.11 according to relative valuation methord.
What is National Health Investors Inc (NHI) fair value?
How does NHI's valuation metrics compare to the industry average?
What is the current P/B ratio for National Health Investors Inc (NHI) as of Aug 14 2025?
What is the current FCF Yield for National Health Investors Inc (NHI) as of Aug 14 2025?
What is the current Forward P/E ratio for National Health Investors Inc (NHI) as of Aug 14 2025?